Embryonic microenvironment suppresses YY1 and YY1-related genes in prostate cancer stem cells.

Cancer stem cell Embryonic microenvironment Prostate cancer Reprogramming yin yang 1

Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
15 Jul 2024
Historique:
received: 09 05 2024
revised: 03 07 2024
accepted: 12 07 2024
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 24 7 2024
Statut: aheadofprint

Résumé

Yin yang 1 (YY1), a transcription factor, plays crucial roles in cell fate specification, differentiation, and pluripotency during embryonic development. It is also involved in tumorigenesis, drug resistance, metastasis, and relapse caused by cancer stem cells (CSCs), particularly in prostate cancer (PCa). Targeting YY1 could potentially eliminate prostate CSCs (PCSCs) and provide novel therapeutic approaches. PCa tissues often exhibit elevated YY1 expression levels, especially in high-grade cases. Notably, high-grade PCa tissues from 58 PCa patients and CD133

Identifiants

pubmed: 39047662
pii: S0344-0338(24)00378-9
doi: 10.1016/j.prp.2024.155467
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

155467

Informations de copyright

Copyright © 2024 Elsevier GmbH. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Aysegul Taskiran (A)

Ege University Faculty of Medicine Department of Histology and Embryology, İzmir 35100, Turkey.

Gulperi Oktem (G)

Ege University Faculty of Medicine Department of Histology and Embryology, İzmir 35100, Turkey; Ege University Institute of Health Sciences Department of Stem Cell, İzmir 35100, Turkey.

Aleyna Demir (A)

Ege University Faculty of Medicine Department of Histology and Embryology, İzmir 35100, Turkey.

Fatih Oltulu (F)

Ege University Faculty of Medicine Department of Histology and Embryology, İzmir 35100, Turkey.

Emine Ozcinar (E)

İzmir Tinaztepe University Department of Histology and Embryology, İzmir 35400, Turkey.

Fahriye Duzagac (F)

University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Prevention, Texas, Houston, TX 77030, USA.

Ummu Guven (U)

Università degli Studi di Milano Department of Biosciences, Milan 20122, Italy.

Emre Karakoc (E)

Wellcome Sanger Institute Translational Cancer Genomics, Hinxton, Cambridge CB10 1SA, UK.

Asli Cakir (A)

Istanbul Medipol University Faculty of Medicine Department of Pathology, İstanbul 34810, Turkey.

Sule Ayla (S)

Istanbul Medeniyet University Faculty of Medicine Department of Histology and Embryology, İstanbul 34700, Turkey.

Selcuk Guven (S)

Necmettin Erbakan University Meram Medical Faculty Department of Urology, Konya 42090, Turkey.

Eda Acikgoz (E)

Van Yuzuncu Yil University, Faculty of Medicine, Department of Histology and Embryology, Van 65090, Turkey. Electronic address: edaacikgoz@yyu.edu.tr.

Classifications MeSH